My thoughts
Three Pathways, One Research Peptide Retatrutide is distinguished by its simultaneous activity across three key metabolic receptor systems: GLP-1, GIP, and glucagon (GCGR)
Methods Using a subset of Truveta Data, we identified patients with any medication dispense (e.g., medication fill) of a GLP-1 RA (semaglutide AOM, semaglutide ADM oral, semaglutide ADM injectable, liraglutide ADM, exenatide ADM, lixisenatide ADM, tirzepatide ADM, and dulaglutide ADM) between January 2018 and October 2023
And the best part is the food noise that no longer takes over my daily thoughts
Montoyo, H
Labeling advises caution and monitoring of renal function, especially if significant gastrointestinal symptoms occur